International Clinical Trial: Testing whether a commonly used drug to treat Diabetes can reduce injury to the lung following heart surgery and in critical illness

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN13139487) titled 'Testing whether a commonly used drug to treat Diabetes can reduce injury to the lung following heart surgery and in critical illness' on Dec. 24, 2025.

Study Type: Interventional

Study Design: Interventional randomized controlled trial (Efficacy, Safety)

Primary Sponsor: Belfast Health and Social Care Trust

Condition: Acute Respiratory Distress Syndrome, post-operative coronary artery bypass graft patients Respiratory

Intervention: Patients will be randomised 1:1 to either a standard care arm or treatment (metformin arm) using the sealed envelope platform. In the treatment arm of the trial, patients will re...